Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Veeva Systems Inc.NYSE: VEEV

Depreciation & Amortization · Q2 FY2027 · quarter ended Jul 2026

Depreciation & amortization declines year over year

Q2 FY2027 depreciation & amortization of $10.87M fell 17.5% year over year, behind the -5.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 26.9% from the prior quarter. Over 3 fiscal years it compounded at +10.3% a year.

Context

  • Depreciation & amortization amounted to 1.6% of revenue in FY2026, down 0.3 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -17.5% toward the trailing-twelve-month pace of -5.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$10.87M-26.9% QoQ
Last fiscal yearJan 2026
$50.47M-0.9% YoY
LTMJul 2026
$46.86M-5.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.5%——
1 year-0.9%——
3-year CAGR+10.3%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2026
50.47M USD
Year-over-year change
-0.9%
4-year CAGR
+8.1%

Depreciation & Amortization vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 depreciation & amortization of $46.86M is the 2nd largest of the 5 companies compared; the peer median is $30.42M.
  • Its year-over-year change of -5.0% is the 3rd highest of 5, against a peer median of -1.1%.
  • Depreciation & amortization amounts to 1.4% of revenue for VEEV, versus a peer median of 4.7%.
VEEV Competitors Peer median
Depreciation & Amortization for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$1.18B +5.4%+0.4%7.0%
VEEVVeeva Systems Inc.LTM Jul 2026$46.86M -5.0%+10.3%1.4%
HSTMHealthStream, Inc.LTM Mar 2026$44.09M -8.3%-3.6%14.1%
DOCSDoximity, Inc.LTM Sep 2026$16.76M +42.7%+11.8%2.5%
SDGRSchrödinger, Inc.LTM Sep 2026$5.86M -7.7%+11.5%2.2%
Peer median (excluding VEEV) $30.42M-1.1%+6.0%4.7%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Net Income427.39M487.71M525.71M714.14M908.91M
Depreciation & Amortization36.97M37.66M37.15M50.93M50.47M
Deferred Income Tax11.08M(127.5M)(105.37M)(112.27M)65.09M
Stock-Based Compensation0000472.7M
Change in Working Capital20.66M7.34M60.82M7.62M(91.94M)
Accounts Receivables(83.08M)(91.09M)(104M)(168.97M)(254.55M)
Inventory00000
Accounts Payables(3M)21.43M(10.23M)(1.96M)6.08M
Other Working Capital106.74M77M175.05M178.55M156.53M
Other Non-Cash Items268.37M375.26M393.03M429.64M9.99M
Operating Cash Flow764.46M780.47M911.34M1.09B1.42B
Capital Expenditures(14.21M)(13.51M)(26.2M)(20.52M)(29.13M)
Acquisitions (Net)(7.78M)0000
Purchases of Investments(1.12B)(2B)(2.7B)(2.58B)(3.13B)
Sales of Investments792.92M1B1.65B1.9B2.06B
Other Investing Activities00000
Investing Cash Flow(346.15M)(1.01B)(1.08B)(700.14M)(1.1B)
Debt Repayment(384K)0000
Common Stock Issued51.54M43.65M62.69M105.54M253.86M
Common Stock Repurchased0000(169.95M)
Dividends Paid00000
Other Financing Activities(55.29M)(63.03M)(78.88M)(79.42M)(93.25M)
Financing Cash Flow(4.14M)(19.38M)(16.19M)26.12M(9.33M)
Effect of Forex Changes(4.66M)(4.99M)(1.78M)(1.74M)919K
Net Change in Cash409.51M(251.58M)(182.98M)414.29M302.45M
Free Cash Flow750.25M766.96M885.14M1.07B1.39B

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.